 |
|
|
| |
SWITCHING TO TAF IN EVG-BASED REGIMENS: CSF PHARMACOKINETICS AND ANTIVIRAL ACTIVITY
|
| |
| |
Poster pdf attached to see Table 1.
Download the PDF here
Reported by Jules Levin
CROI 2018 March 4-7 Boston MA
Qing Ma1, Andrew J. Ocque1, Gene D. Morse1, Chelsea Sanders2, Alina Burgi2, Susan J.
Little2, Scott L. Letendre2
1University at Buffalo, Buffalo, New York, USA; 2University of California San Diego, La Jolla, California, USA
|
| |
|
|
|
|
|
